KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Assets (2016 - 2025)

Historic Return on Assets for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to 0.01%.

  • Supernus Pharmaceuticals' Return on Assets fell 600.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.06% for FY2024, which is 500.0% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Return on Assets stood at 0.01%, which was down 600.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Return on Assets ranged from a high of 0.07% in Q1 2021 and a low of 0.01% during Q3 2025
  • Over the past 5 years, Supernus Pharmaceuticals' median Return on Assets value was 0.03% (recorded in 2022), while the average stood at 0.03%.
  • The largest annual percentage gain for Supernus Pharmaceuticals' Return on Assets in the last 5 years was 600bps (2025), contrasted with its biggest fall of -600bps (2025).
  • Supernus Pharmaceuticals' Return on Assets (Quarter) stood at 0.03% in 2021, then rose by 9bps to 0.04% in 2022, then plummeted by -97bps to 0.0% in 2023, then surged by 5337bps to 0.05% in 2024, then plummeted by -125bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.05% for Q2 2025, and 0.05% during Q1 2025.